西方早期食管鳞状细胞癌环周内镜黏膜下剥离术的结局
这项国际研究纳入欧洲和澳大利亚25个转诊中心165例患者的171次环周内镜黏膜下剥离术,整块切除率98.2%、R0切除率69.6%、治愈性切除率49.1%,非治愈最常见原因为深部黏膜下浸润(21.6%);尽管93%的操作采用了预防措施,需6次以上扩张或额外技术干预的狭窄风险仍高达71%。
要点
- 环周内镜黏膜下剥离术治疗早期食管鳞癌的整块切除率为98.2%,R0切除率为69.6%。
- 治愈性切除率为49.1%,非治愈最常见原因是深部黏膜下浸润(21.6%)。
- 需6次以上扩张或额外技术的狭窄风险为71%,尽管93%的操作采用了预防措施。
核心结论
- 在西方转诊中心,环周内镜黏膜下剥离术治疗食管鳞状细胞癌约半数病灶可达治愈性切除。
- 作者认为该技术可考虑用于经过选择的患者。
- 作者认为结果提示需要改进患者选择并开发更有效的食管狭窄预防疗法。
研究设计与样本
- 国际研究,纳入欧洲和澳大利亚25个转诊中心的前瞻性数据库。
- 纳入2022年11月前接受环周内镜黏膜下剥离术治疗的所有食管鳞状细胞癌患者。
- 共对165例患者实施了171次环周内镜黏膜下剥离术。
主要发现
- 整块切除率为98.2%(95%CI 95.0-99.4),R0切除率为69.6%(95%CI 62.3-76.0)。
- 治愈性切除率为49.1%(95%CI 41.7-56.6),非治愈最常见原因为深部黏膜下浸润(21.6%)。
- 需6次以上扩张或额外技术(切开治疗/支架)的狭窄风险为71%,尽管93%的操作采用了预防措施。
- 术中穿孔率4.1%,迟发出血率0.6%,不良心肺事件率4.7%。
- 2例患者(1.2%)死于环周内镜黏膜下剥离术相关不良事件;2年总生存率91%,无病生存率79%。
关键数值与推荐
- 治愈性切除按欧洲指南判定,49.1%(95%CI 41.7-56.6)的病灶达到治愈性切除。
临床怎么用
- 作者认为,在西方转诊中心,环周内镜黏膜下剥离术可考虑作为经过选择的食管鳞状细胞癌患者的可行治疗。
- 作者认为需要改进患者选择并开发更有效的食管狭窄预防疗法。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Circumferential endoscopic submucosal dissection (cESD) in the esophagus has been reported to be feasible in small Eastern case series. We assessed the outcomes of cESD in the treatment of early esophageal squamous cell carcinoma (ESCC) in Western countries. METHODS: We conducted an international study at 25 referral centers in Europe and Australia using prospective databases. We included all patients with ESCC treated with cESD before November 2022. Our main outcomes were curative resection according to European guidelines and adverse events. RESULTS: A total of 171 cESDs were performed on 165 patients. En bloc and R0 resections rates were 98.2% (95% confidence interval [CI], 95.0-99.4) and 69.6% (95% CI, 62.3-76.0), respectively. Curative resection was achieved in 49.1% (95% CI, 41.7-56.6) of the lesions. The most common reason for noncurative resection was deep submucosal invasion (21.6%). The risk of stricture requiring 6 or more dilations or additional techniques (incisional therapy/stent) was high (71%), despite the use of prophylactic measures in 93% of the procedures. The rates of intraprocedural perforation, delayed bleeding, and adverse cardiorespiratory events were 4.1%, 0.6%, and 4.7%, respectively. Two patients died (1.2%) of a cESD-related adverse event. Overall and disease-free survival rates at 2 years were 91% and 79%. CONCLUSIONS: In Western referral centers, cESD for ESCC is curative in approximately half of the lesions. It can be considered a feasible treatment in selected patients. Our results suggest the need to improve patient selection and to develop more effective therapies to prevent esophageal strictures.
引用
- Rodríguez de Santiago E, van Tilburg L, Deprez PH, et al. Western outcomes of circumferential endoscopic submucosal dissection for early esophageal squamous cell carcinoma. Gastrointest Endosc. 2023. PMID: 37879543. doi:10.1016/j.gie.2023.10.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。